Sign In
Buy INVA
$21.70
+0.350 (+1.64%)
At Close: Jun 03, 2026
GSK tells UK staff: turn off Covid test-and-trace app while at work
05:36pm, Tuesday, 06'th Oct 2020
Drugs company says infection controls at some of its sites are so secure the app is not needed
Covid treatment hopes as GlaxoSmithKline drug moves onto phase 3 trial
03:08pm, Tuesday, 06'th Oct 2020
Brentford-based GlaxoSmithKline (GSK) said its treatment - known as Vir-7831 - could be rolled out by 2021 if its proven to be effective and safe.
US-Bundesberufungsgericht bestätigt GSKs 182 Mio. £-Urteil gegen Teva Pharmaceutical | Invezz
12:14am, Tuesday, 06'th Oct 2020
Das US-Bundesberufungsgericht für den Bundeskreis sagte am Freitag, dass Teva Pharmaceutical Industries Ltd (TLV: TEVA) GlaxoSmithKline plc (LON: GSK) mit einer Zahlung von 182,09 Mio. £ entschädig
Vir Biotech, GlaxoSmithKline Advance COVID-19 Antibody Treatment Into Global, Late-Stage Trial
12:00am, Tuesday, 06'th Oct 2020
Vir Biotechnology Inc (NASDAQ: VIR) shares were rallying Tuesday after the company provided an update on its partnered COVID-19 treatment program.
Vir's COVID-19 Antibody...
Federal Circuit Says Teva Induced Infringement of GSK Patent on Congestive Heart Failure Drug
08:15pm, Monday, 05'th Oct 2020
The Federal Circuit on Friday reversed a district court’s motion for judgment as a matter of law for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's patent directed
Nvidia announces partnership with GSK focused on drug discovery
02:06pm, Monday, 05'th Oct 2020
Nvidia Corp. shares undefined are up 3% in Monday trading after the company said it would partner with GlaxoSmithKline PLC undefined to use computing and...
Nvidia Will Help GSK Find New Drugs, With AI and Supercomputers
01:34pm, Monday, 05'th Oct 2020
GSK’s head of AI and machine learning said the Nvidia systems will allow his researchers to search for medicines by poring through vast databases of pathology images and genomic signals.
NVIDIA Building UK's Most Powerful Supercomputer, Dedicated to AI Research in Healthcare
01:09pm, Monday, 05'th Oct 2020
SANTA CLARA, Calif., Oct 05, 2020 (GLOBE NEWSWIRE via COMTEX) -- GTC -- NVIDIA today announced that it is building the United Kingdom's most powerful...
NVIDIA Announces Partnership with GSK's AI-Powered Lab for Discovery of Medicines and Vaccines
01:09pm, Monday, 05'th Oct 2020
SANTA CLARA, Calif., Oct 05, 2020 (GLOBE NEWSWIRE via COMTEX) -- GTC -- NVIDIA today announced a partnership with global healthcare company GSK and its AI...
NVIDIA Building UK's Most Powerful Supercomputer, Dedicated to AI Research in Healthcare
01:09pm, Monday, 05'th Oct 2020
SANTA CLARA, Calif., Oct 05, 2020 (GLOBE NEWSWIRE via COMTEX) --
SANTA CLARA, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- GTC -- NVIDIA today announced that it...
NVIDIA Announces Partnership with GSK's AI-Powered Lab for Discovery of Medicines and Vaccines
01:09pm, Monday, 05'th Oct 2020
SANTA CLARA, Calif., Oct 05, 2020 (GLOBE NEWSWIRE via COMTEX) --
SANTA CLARA, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- GTC -- NVIDIA today announced a...
NVIDIA : Announces Partnership with GSK's AI-Powered Lab for Discovery of Medicines and Vaccines | MarketScreener
01:04pm, Monday, 05'th Oct 2020
El Tribunal de Apelaciones del Circuito Federal de EE.UU. dijo el viernes que Teva Pharmaceutical Industries Ltd (TLV: TEVA) compensará a GlaxoSmithKline plc (LON: GSK) con un pago de £182,09 millon
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented three
